News | Radiation Therapy | August 02, 2019

Varian Showcases Cancer Care Systems and Software at AAPM 2019

Offerings highlighted by Identify guidance system for enhanced patient identification, positioning and motion management during surface-guided radiation therapy

Varian Showcases Cancer Care Systems and Software at AAPM 2019

August 2, 2019 — Varian showcased systems and software from its cancer care portfolio, including the Identify Guidance System, at the recent American Association of Physicists in Medicine (AAPM) 2019 annual meeting, July 14-18  in San Antonio, Texas.

Identify is an automated patient identification, positioning and motion management system for radiation therapy. It incorporates patient safety, quality, efficiency and surface-guidance features in an automated workflow solution for surface-guided radiation therapy (SGRT). 

Other Varian solutions showcased bring together artificial intelligence (AI), data analytics, science and technology, and include:

  • RapidPlan leverages machine learning to help clinicians achieve greater treatment plan consistency, efficiency and quality;
  • Multi-Criteria Optimization (MCO) improves the efficiency and quality of treatment planning by helping clinicians explore clinical tradeoffs when they vary plan parameters;
  • Noona is an intuitive solution for patients to report on their symptoms and outcomes, enabling better symptom monitoring, proactive management, and patient triage; and
  • ProBeam 360° system, designed for next-generation proton therapy, offers high-level clinical capabilities, a 360-degree gantry and RapidScan technology, which simplifies the process of motion management by delivering each field in a single breath-hold

Also on display was the full spectrum of Varian software solutions for: brachytherapy treatment planning and guidance, practice management, radiosurgery delivery, machine quality assurance, imaging informatics, image-guided dosimetry for Y90 selective internal radiation therapy (SIRT), tumor board management and more.

For more information: www.varian.com

Related Content

Researchers at Karolinska Institutet in Sweden and Tampere University in Finland have developed a method based on artificial intelligence (AI) for histopathological diagnosis and grading of prostate cancer

From left: Peter Ström, Martin Eklund, Kimmo Kartasalo, Henrik Olsson och Lars Egevad, researchers at Karolinska Institutet in Sweden. Photo courtesy of Stefan Zimmerman

News | Prostate Cancer | January 20, 2020
January 20, 2020 — Researchers at Karolinska Institutet in Sweden and...
Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population

Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population. Chart courtesy of the American Cancer Society

News | Radiation Oncology | January 13, 2020
January 13, 2020 — The cancer death rate declined
Professor Samer Ezziddin, M.D., from Saarland University/Saarland University Hospital.

Professor Samer Ezziddin, M.D., from Saarland University/Saarland University Hospital. Image courtesy of Saarland University/Thorsten Mohr

 

News | Prostate Cancer | January 13, 2020
January 13, 2020 — When a non-scientist tries to imagine a scientist, the image that often arises is one of a somewha
Lung cancer patients who are inactive prior to chemoradiation are less likely to tolerate treatment and more likely to see their cancer return
News | Lung Cancer | January 08, 2020
January 8, 2020 — Numerous ...
Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Feature | Radiation Oncology | January 03, 2020 | Dave Fornell, Editor
January 3, 2020 — Here is the top 20 pieces of radiation oncology content on the Imaging Technology News (ITN) websit
Artificial intelligence was by far the hottest topic in both radiology and radiation oncology in 2019, and AI is the subject of 8 of the top 2019 ITN videos. This image is a prostate treatment plan created autonomously by an AI algorithm from RaySearch and is the subject of the No. 2 video on the list. Deep learning in radiology and radiation oncology.

Artificial intelligence was by far the hottest topic in both radiology and radiation oncology in 2019, and AI is the subject of 8 of the top 2019 ITN videos. This image is a prostate treatment plan created autonomously by a machine learning algorithm from RaySearch and is the subject of the No. 2 video on the list. 

Feature | December 30, 2019
Here are the top 20 best performing videos posted on the Imaging Technology News website (ITN) from the past year, ba
Ferrotran (formerly Combidex), based on Ferumoxtran-10, is the only contrast agent which can detect lymph node metastases as small as 2 mm diameter

Ferrotran (formerly Combidex), based on Ferumoxtran-10, is the only contrast agent which can detect lymph node metastases as small as 2 mm diameter. Standard MRI or CT are not able to detect lymph node metastases smaller than 7 – 8 mm. Since most of the oncologic patients are dying due to metastases, a precise diagnostic is of utmost importance. The detection of small metastases, combined with the very clear and contrast rich MRI image of Ferrotran, enables an earlier and more precise treatment. Therefore, Ferrotran gives the patient a much higher chance of recovery.

News | Prostate Cancer | December 24, 2019
December 24, 2019 — SPL Medical announced today that the first patient has been successfully diagnosed with suspected